Microbiology

  1. Comparison of seven commercial RT-PCR diagnostic kits for COVID-19

    1. Puck B. van Kasteren
    2. Bas van der Veer
    3. Sharon van den Brink
    4. Lisa Wijsman
    5. Jørgen de Jonge
    6. Annemarie van den Brandt
    7. Richard Molenkamp
    8. Chantal B.E.M. Reusken
    9. Adam Meijer

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. The anti‐HIV drug nelfinavir mesylate (Viracept) is a potent inhibitor of cell fusion caused by the SARSCoV‐2 spike (S) glycoprotein warranting further evaluation as an antiviral against COVID‐19 infections

    1. Farhana Musarrat
    2. Vladimir Chouljenko
    3. Achyut Dahal
    4. Rafiq Nabi
    5. Tamara Chouljenko
    6. Seetharama D. Jois
    7. Konstantin G. Kousoulas

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. SARS-CoV-2 isolation and propagation from Turkish COVID-19 patients

    1. Cihan TAŞTAN
    2. Bulut YURTSEVER
    3. Gözde SIR KARAKUŞ
    4. Derya DİLEK KANÇAĞI
    5. Sevda DEMİR
    6. Selen ABANUZ
    7. Utku SEYİS
    8. Mülazim YILDIRIM
    9. Recai KUZAY
    10. Ömer ELİBOL
    11. Serap ARBAK
    12. Merve AÇIKEL ELMAS
    13. Selçuk BİRDOĞAN
    14. Osman Uğur SEZERMAN
    15. Ayşe Sesin KOCAGÖZ
    16. Koray YALÇIN
    17. Ercüment OVALI

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Mapping the Immunodominance Landscape of SARS-CoV-2 Spike Protein for the Design of Vaccines against COVID-19

    1. Bao-zhong Zhang
    2. Ye-fan Hu
    3. Lin-lei Chen
    4. Yi-gang Tong
    5. Jing-chu Hu
    6. Jian-piao Cai
    7. Kwok-Hung Chan
    8. Ying Dou
    9. Jian Deng
    10. Hua-rui Gong
    11. Chaiyaporn Kuwentrai
    12. Wenjun Li
    13. Xiao-lei Wang
    14. Hin Chu
    15. Cai-hui Su
    16. Ivan Fan-Ngai Hung
    17. Thomas Chung Cheung Yau
    18. Kelvin Kai-Wang To
    19. Kwok Yung Yuen
    20. Jian-Dong Huang

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. STAT2 signaling as double-edged sword restricting viral dissemination but driving severe pneumonia in SARS-CoV-2 infected hamsters

    1. Robbert Boudewijns
    2. Hendrik Jan Thibaut
    3. Suzanne J. F. Kaptein
    4. Rong Li
    5. Valentijn Vergote
    6. Laura Seldeslachts
    7. Carolien De Keyzer
    8. Lindsey Bervoets
    9. Sapna Sharma
    10. Johan Van Weyenbergh
    11. Laurens Liesenborghs
    12. Ji Ma
    13. Sander Jansen
    14. Dominique Van Looveren
    15. Thomas Vercruysse
    16. Dirk Jochmans
    17. Xinyu Wang
    18. Erik Martens
    19. Kenny Roose
    20. Dorien De Vlieger
    21. Bert Schepens
    22. Tina Van Buyten
    23. Sofie Jacobs
    24. Yanan Liu
    25. Joan Martí-Carreras
    26. Bert Vanmechelen
    27. Tony Wawina-Bokalanga
    28. Leen Delang
    29. Joana Rocha-Pereira
    30. Lotte Coelmont
    31. Winston Chiu
    32. Pieter Leyssen
    33. Elisabeth Heylen
    34. Dominique Schols
    35. Lanjiao Wang
    36. Lila Close
    37. Jelle Matthijnssens
    38. Marc Van Ranst
    39. Veerle Compernolle
    40. Georg Schramm
    41. Koen Van Laere
    42. Xavier Saelens
    43. Nico Callewaert
    44. Ghislain Opdenakker
    45. Piet Maes
    46. Birgit Weynand
    47. Christopher Cawthorne
    48. Greetje Vande Velde
    49. Zhongde Wang
    50. Johan Neyts
    51. Kai Dallmeier

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect after a Drug Repurposing Screen

    1. Jordi Rodon
    2. Jordana Muñoz-Basagoiti
    3. Daniel Perez-Zsolt
    4. Marc Noguera-Julian
    5. Roger Paredes
    6. Lourdes Mateu
    7. Carles Quiñones
    8. Itziar Erkizia
    9. Ignacio Blanco
    10. Alfonso Valencia
    11. Víctor Guallar
    12. Jorge Carrillo
    13. Julià Blanco
    14. Joaquim Segalés
    15. Bonaventura Clotet
    16. Júlia Vergara-Alert
    17. Nuria Izquierdo-Useros

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. ACE2 polymorphisms and individual susceptibility to SARS-CoV-2 infection: insights from an in silico study

    1. Matteo Calcagnile
    2. Patricia Forgez
    3. Antonio Iannelli
    4. Cecilia Bucci
    5. Marco Alifano
    6. Pietro Alifano

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Critical role of type III interferon in controlling SARS-CoV-2 infection, replication and spread in primary human intestinal epithelial cells

    1. Megan L. Stanifer
    2. Carmon Kee
    3. Mirko Cortese
    4. Sergio Triana
    5. Markus Mukenhirn
    6. Hans-Georg Kraeusslich
    7. Theodore Alexandrov
    8. Ralf Bartenschlager
    9. Steeve Boulant

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. The anticoagulant nafamostat potently inhibits SARS-CoV-2 infection in vitro : an existing drug with multiple possible therapeutic effects

    1. Mizuki Yamamoto
    2. Maki Kiso
    3. Yuko Sakai-Tagawa
    4. Kiyoko Iwatsuki-Horimoto
    5. Masaki Imai
    6. Makoto Takeda
    7. Noriko Kinoshita
    8. Norio Ohmagari
    9. Jin Gohda
    10. Kentaro Semba
    11. Zene Matsuda
    12. Yasushi Kawaguchi
    13. Yoshihiro Kawaoka
    14. Jun-ichiro Inoue

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Structural and Biochemical Characterization of the nsp12-nsp7-nsp8 Core Polymerase Complex from SARS-CoV-2

    1. Qi Peng
    2. Ruchao Peng
    3. Bin Yuan
    4. Jingru Zhao
    5. Min Wang
    6. Xixi Wang
    7. Qian Wang
    8. Yan Sun
    9. Zheng Fan
    10. Jianxun Qi
    11. George F. Gao
    12. Yi Shi

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 63 of 246 Next